Sanofi has begun a comprehensive review of compounds, leads, patents and technologies in our pipeline.
Our objective is to identify those with potential for out-licensing or other appropriate forms of partnering. This is a new initiative to create long-term value. We are flexible, and as we progress in our review, we will be open to exchanging ideas towards establishing creative partnerships.
American Diabetes Association (ADA) 73rd Scientific Sessions 2013
June 21-25, 2013
Partnering press releases
March 25, 2013
© Sanofi 2004-2014 - All rights reserved - Update: July 04, 2013